The Impact of Substance Use on Mother-to-child Transmission of HIV
This literature review aimed to assess the impact of substance use on mother-to-child transmission (MTCT) of HIV. Such a review was deemed necessary due to Saskatchewan’s unique HIV profile. Specifically, new cases of HIV in Saskatchewan are: (a) the highest in Canada; (b) most often associated with injection drug use (IDU); and (c) increasing rapidly in women of childbearing age (ages 15 to 39). The primary questions addressed in the report include: Why do substance use services need to be focused on to avoid MTCT of HIV? How does having a substance use issue influence high risk behaviours that can lead to HIV infection? How does having a substance use issue affect virus progression and impact the health of pregnant women living with HIV?
Screening for HIV as Part of Prenatal Care Prior to Week 36
This algorithm provides Saskatchewan-specific guidelines for HIV screening in pregnant women prior to 36 weeks gestation.
Planning a Pregnancy When HIV Positive
This brochure talks about caring for your body before getting pregnant and what is involved with HIV treatment during pregnancy. It also talks about getting pregnant safely and how finding a good obstetric healthcare provider and support is important.SKU: 7-005
Pregnant and Diagnosed with HIV
Finding out that you are HIV positive can be overwhelming and scary. Finding out you are HIV positive while you are pregnant can cause more fear and can raise questions about the impact this diagnosis will have on both you and your new baby. This brochure explains what HIV/AIDS is and how it can be treated.SKU: 7-006
Substance Use, Pregnancy, and HIV/AIDS: Treatment Programs for Pregnant Women
This living document identifies existing substance use treatment programs and services available to pregnant women and pregnant women living with HIV/AIDS in North America, with a particular focus on Saskatchewan. The information provided through the current environmental scan is useful both for pregnant women who use substances who are seeking services, and for healthcare professionals, who can use this information to assist women in accessing services that are appropriate to their needs. Ideally, this would be done as part of a multidisciplinary team, where the referring professional continues to be involved in the care of the woman. It is hoped that the information provided will increase awareness of the existing substance use treatment centres and programs for pregnant women, with the goal of potentially increasing referrals to and use of these programs.